Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
8m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
8m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
32m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
32m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
32m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

Xtl Biopharmaceuticals Ltd

About

Xtl Biopharmaceuticals Ltd (TA:XTLB) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 20 2026
XTL Biopharmaceuticals Announces ADS Ratio Change
Feb 27 2026
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
Jan 29 2026
XTL Update on Recent Developments
Jan 23 2026
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
Jan 13 2026
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Financials

Revenue
ILA968 K
Market Cap
ILA18.92 M
EPS
-0.03

Community Chat

Ask AI

6ix6ixAIEvents